Latest filing published 23 Jul 2013 for OncoMed Pharmaceuticals Inc.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
James W. Broderick: trading record in brief
James W. Broderick discloses dealings in OncoMed Pharmaceuticals Inc to SEC (Form 4). We count 4 filings, every one of them for a trade on 23 July 2013.
Purchases make up the whole of the open-market record (1 purchase, €907k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
On 23 July 2013 came the latest disclosure, a transaction in OncoMed Pharmaceuticals Inc. The last insider purchase was made public on 23 July 2013, 4,857 days ago. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to James W. Broderick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 710,526 sharesCommon StockSEC:0001181431-13-041156:0
- 834,732 sharesCommon StockSEC:0001181431-13-041156:1
- 893,825 sharesCommon StockSEC:0001181431-13-041156:2
3 of 3 declarations
